The U.S. government should focus even more closely on maintaining a fair and open competition. Some companies will succeed, others will fail, but overall, investors – and the whole country – will adapt and be better off. The ability to fail is one of the secret weapons of our system. Continue Reading
Following the revelation that He Jiankui, a scientist in China, genetically edited human embryos and implanted them in women, the scientific community has pushed for an international regulatory system to oversee controversial and potentially dangerous research. Continue Reading
The authors explain why $100 billion allocated by the CARES act to compensate health care providers for unreimbursed expenses and lost revenue may be woefully inadequate.
In a less spectacular fashion than oil, international natural gas prices have fallen. The explanation goes far beyond low demand related to the Covid-19 pandemic or demand in general. It relies on a much larger and more complicated array of factors that include supply and demand and oil pricing. Continue Reading
Even before the pandemic, Mexico’s health care system was in crisis, with shortages of medical supplies, drugs, and personnel. A president that is downplaying the outbreak, brandishing amulets to “protect” him from the virus, isn’t helping matters. Continue Reading
Based on updated Covid-19 data, Houston must seriously prepare for a Covid-19 surge in mid-April, possibly related to the Houston Rodeo mass crowding and/or an influx of Covid-19 positive cases from Louisiana. The next month will clarify better how Covid-19 will affect our lives and economies. Continue Reading
In this post, the authors discuss the main provisions of three emergency funding bills passed by Congress and then discuss general rules for evaluating current and future policies designed to mitigate long-term damage to the economy from the coronavirus pandemic. Continue Reading